Skip to main content

Table 2 Hazard ratios for cancer specific and all cause mortality for patients with specified co-morbidities

From: The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study

 

Crude HR

 

Adjusted for pt factors1

 

Adjusted for pt and disease factors2

 

Cancer specific mortality

Angina

0.74

0.48–1.15

0.75

0.48–1.19

0.81

0.51–1.30

Hypertension

0.97

0.74–1.27

0.96

0.72–1.28

0.92

0.69–1.23

Previous MI

1.23

0.77–1.97

1.30

0.81–2.11

1.49

0.90–2.46

Cardiac arrhythmias

0.82

0.54–1.25

0.88

0.57–1.36

1.17

0.74–1.83

CHF

1.13

0.74–1.75

1.10

0.70–1.72

1.83

1.14–2.93

PVD

0.64

0.26–1.55

0.71

0.39–1.75

1.18

0.48–2.93

Chronic respiratory disease

1.16

0.85–1.58

1.06

0.77–1.46

1.24

0.89–1.74

GI ulcer disease

0.49

0.20–1.18

0.50

0.21–1.22

0.76

0.31–1.87

Other cancer

0.77

0.36–1.63

0.79

0.37–1.71

0.71

0.32–1.55

Cerebrovasc disease

1.23

0.75–2.02

1.30

0.78–2.16

1.25

0.74–2.10

Diabetes (all)

1.18

0.84–1.68

1.14

0.79–1.63

1.27

0.88–1.84

Renal disease (all)

1.10

0.60–2.01

1.01

0.54–1.87

1.42

0.76–2.66

Other neurological

1.19

0.71–1.97

1.35

0.80–2.25

1.96

1.12–3.42

Charlson comorbidity index

      

   O

1.00

 

1.00

 

1.00

 

   1–2

1.26

0.96–1.66

1.22

0.91–1.64

1.32

0.98–1.77

   3+

0.86

0.52–1.42

0.88

0.53–1.47

1.48

0.88–2.50

Number of conditions*

      

   0

1.00

 

1.00

 

1.00

 

   1

1.30

0.93–1.80

1.29

0.92–1.83

1.06

0.76–1.55

   2

1.15

0.79–1.68

1.13

0.75–1.70

1.23

0.81–1.87

   3+

1.00

0.69–1.45

1.01

0.67–1.53

1.33

0.87–2.04

All-cause mortality

Angina

0.96

0.68–1.34

0.86

0.61–1.23

0.91

0.63–1.31

Hypertension

1.03

0.82–1.29

0.93

0.73–1.19

0.90

0.70–1.15

Previous MI

1.67

1.17–2.38

1.74

1.21–2.52

1.91

1.31–2.79

Cardiac arrhythmias

1.26

0.93–1.72

1.19

0.86–1.65

1.48

1.07–2.06

CHF

1.79

1.31–2.45

1.61

1.16–2.24

2.30

1.63–3.25

PVD

1.46

0.87–2.46

1.40

0.82–2.40

2.02

1.18–3.48

Chronic respiratory disease

1.29

0.99–1.66

1.12

0.85–1.46

1.26

0.96–1.66

GI ulcer disease

0.61

0.32–1.19

0.60

0.31–1.17

0.76

0.38–1.49

Other cancer

1.31

0.79–2.16

1.25

0.74–2.10

1.16

0.68–1.98

Cerebrovasc disease

1.36

0.91–2.04

1.28

0.85–1.93

1.27

0.84–1.94

Diabetes (all)

1.48

1.12–1.95

1.44

1.08–1.92

1.53

1.15–2.05

Renal disease (all)

1.52

0.96–2.39

1.32

0.83–2.10

1.79

1.12–2.86

Other neurological

1.44

0.97–2.16

1.58

1.05–2.38

2.02

1.32–3.11

CCI

      

   O

1.00

 

1.00

 

1.00

 

   1–2

1.68

1.32–2.14

1.55

1.20–2.00

1.60

1.24–2.07

   3+

1.84

1.30–2.60

1.78

1.24–2.55

2.63

1.82–3.81

Number of conditions*

      

   0

1.00

 

1.00

 

1.00

 

   1

1.30

0.95–1.78

1.26

0.92–1.73

1.08

0.78–1.49

   2

1.50

1.08–2.08

1.40

0.98–1.99

1.45

1.01–2.07

   3+

1.73

1.28–2.35

1.63

1.17–2.28

2.00

1.41–2.82

  1. 1 includes age, sex, ethnicity, NZdep, year of registration, smoking
  2. 2 includes age, sex, ethnicity, NZdep, year of registration, smoking, stage, grade and site of cancer
  3. * Included all conditions included in Charlson Comorbidity Index as well as angina, hypertension, cardiac arrhythmias, previous pulmonary embolism, cardiac valve disease, inflammatory bowel disease, other neurological conditions (including multiple sclerosis, Parkinson's disease, epilepsy) and major psychiatric conditions (including schizophrenia, bipolar disease and depressive psychosis)
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us